Whole Genome Sequencing Application

Whole genome sequencing application enables comprehensive genetic characterisation informing disease mechanism and treatment selection. Variant identification detects disease-causing mutations. Pharmacogenetic profiling predicts drug response. Copy number variation assessment detects structural abnormalities. Clinical interpretation of variants requires expertise.

Regulatory submissions increasingly incorporate sequencing data. Biomarker discovery identifies novel disease mechanisms. Clinical utility validation confirms treatment benefit. Post-approval monitoring employs sequencing surveillance. Emerging interpretation improves clinical application.